China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Increase in western Pacific military activities noted
- China, Pakistan pledge deeper military ties
- SPP to oversee handling of Shanxi mine explosion case
- Mine blast victims get mental health counseling
- China leads with ‘deep and real’ methane control efforts, expert says
- China calls for fair global ocean governance in Xiamen symposium
